T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Rocket Lab Corp
RKLB
$51.2B
| $252K | ﹤0.01% |
61,884
-1,067,758
| -95% | -$5.27M |
|
2452
RGC Resources
RGCO
$226M
| $251K | ﹤0.01% |
11,879
-793,157
| -99% | -$16.5M |
|
|
AAIC
2453
DELISTED
Arlington Asset Investment Corp.
AAIC
| $251K | ﹤0.01% |
92,100
| – | – |
|
2454
Royal Bank of Canada
RY
$299B
| $250K | ﹤0.01% |
2,770
-56,171
| -95% | -$5.39M |
|
|
BRSL
2455
Brightstar Lottery PLC
BRSL
$2.15B
| $249K | ﹤0.01% |
+15,748
| New | +$295K |
|
|
NOTV
2456
DELISTED
Inotiv
NOTV
| $249K | ﹤0.01% |
+14,753
| New | +$271K |
|
2457
Axogen
AXGN
$2.58B
| $248K | ﹤0.01% |
20,755
+2,526
| +14% | +$25.3K |
|
|
AAN
2458
DELISTED
The Aaron's Company Inc
AAN
| $248K | ﹤0.01% |
25,490
+1,787
| +8% | +$23.8K |
|
2459
Western New England Bancorp
WNEB
$282M
| $245K | ﹤0.01% |
30,100
| – | – |
|
|
WW
2460
DELISTED
WW International
WW
| $245K | ﹤0.01% |
62,208
+26,145
| +72% | +$158K |
|
|
CIO
2461
DELISTED
City Office REIT
CIO
| $244K | ﹤0.01% |
24,468
-28,942
| -54% | -$357K |
|
2462
Ocugen
OCGN
$458M
| $244K | ﹤0.01% |
136,822
+12,800
| +10% | +$31.9K |
|
2463
Sturm, Ruger & Co
RGR
$601M
| $244K | ﹤0.01% |
4,789
+1,237
| +35% | +$71.5K |
|
2464
SIGA Technologies
SIGA
$207M
| $243K | ﹤0.01% |
23,507
+2,723
| +13% | +$43.8K |
|
|
YMAB
2465
DELISTED
Y-mAbs Therapeutics
YMAB
| $241K | ﹤0.01% |
16,708
+2,285
| +16% | +$37.8K |
|
|
FRG
2466
DELISTED
Franchise Group, Inc.
FRG
| $241K | ﹤0.01% |
9,892
+1,654
| +20% | +$54.3K |
|
2467
MGP Ingredients
MGPI
$389M
| $240K | ﹤0.01% |
+2,260
| New | +$243K |
|
2468
Mesa Laboratories
MLAB
$633M
| $240K | ﹤0.01% |
1,703
+320
| +23% | +$58.4K |
|
2469
Liberty Latin America Class A
LILA
$1.67B
| $237K | ﹤0.01% |
56,233
+4,726
| +9% | +$22.8K |
|
2470
Liquidity Services
LQDT
$1.35B
| $237K | ﹤0.01% |
14,534
+4,055
| +39% | +$71.3K |
|
|
VVNT
2471
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $237K | ﹤0.01% |
35,911
+17,398
| +94% | +$97.6K |
|
2472
Gorman-Rupp
GRC
$2.11B
| $235K | ﹤0.01% |
9,869
-2,747
| -22% | -$74.5K |
|
2473
Aemetis
AMTX
$126M
| $234K | ﹤0.01% |
38,207
+8,700
| +29% | +$66.2K |
|
2474
InvenTrust Properties
IVT
$2.62B
| $234K | ﹤0.01% |
+10,940
| New | +$291K |
|
2475
Century Aluminum
CENX
$4.59B
| $232K | ﹤0.01% |
43,870
-3,634
| -8% | -$27.6K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.